Enrolling by invitationNot applicableNCT04498026
Adherus™ Dural Sealant in Spinal Procedures
Studying Isolated femoral agenesis/hypoplasia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Stryker Craniomaxillofacial
- Intervention
- Adherus Dural Sealant System(device)
- Enrollment
- 114 target
- Eligibility
- 18-75 years · All sexes
- Timeline
- 2020 – 2025
Study locations (14)
- City of Hope National Medical Center, Duarte, California, United States
- University of California Davis Health, Sacramento, California, United States
- Stanford University, Stanford, California, United States
- Mayo Clinic (FL), Jacksonville, Florida, United States
- Rush University Medical Center, Chicago, Illinois, United States
- University of Illinois at Chicago, Chicago, Illinois, United States
- Mayo Clinic, Rochester, Minnesota, United States
- Columbia University Irving Medical Center, New York, New York, United States
- Carolina Neurosurgery & Spine Associates, Charlotte, North Carolina, United States
- Duke University, Durham, North Carolina, United States
- Thomas Jefferson University, Philadelphia, Pennsylvania, United States
- Houston Methodist Research Institute, Houston, Texas, United States
- University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States
- Carilion Clinic, Roanoke, Virginia, United States
Collaborators
Fortrea
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04498026 on ClinicalTrials.govOther trials for Isolated femoral agenesis/hypoplasia
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07539792Efficacy and Safety Evaluation of Absorbable and Moldable Skull Base Support Plates in Extended Endoscopic Endonasal Transsphenoidal Surgery: A Prospective, Randomized, Controlled StudyNanfang Hospital, Southern Medical University
- ACTIVE NOT RECRUITINGNCT07151794G8, CARG, Frailty, and Nutritional Markers in Predicting ChemotoxicityÇanakkale Onsekiz Mart University
- RECRUITINGEARLY PHASE1NCT06216938RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node MetastasisYana Najjar
- RECRUITINGNCT06164483Auditory Functions in Patients With Multiple SclerosisUniversity of Catania
- RECRUITINGPHASE2NCT05817214Cadonilimab Plus Anlotinib for R/M/P Cervical CancerZhongnan Hospital
- RECRUITINGNANCT04099823MR Evaluation of Cerebrospinal Fluid (CSF) DynamicsMayo Clinic
- RECRUITINGPHASE1, PHASE2NCT03866525OH2 Oncolytic Viral Therapy in Solid TumorsBinhui Biopharmaceutical Co., Ltd.
- RECRUITINGPHASE1, PHASE2NCT04386967OH2 Injection in Solid TumorsBinhui Biopharmaceutical Co., Ltd.